Taken together these data demonstrate that patients with RCC have increased levels of sTREM-1 in their blood compared with healthy donors and that tumor-associated Trem1 correlates with high disease stage, primary tumor size, and poor outcomes in RCC. The gene discussed is TREM1; the disease is neoplasm.